Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2012 (2012), Article ID 150842, 12 pages
http://dx.doi.org/10.1155/2012/150842
Research Article

Morphine and Clonidine Synergize to Ameliorate Low Back Pain in Mice

Maral Tajerian,1,2,3 Magali Millecamps,1,2,4 and Laura S. Stone1,2,3,4,5,6

1Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada H3G 0G1
2McGill Scoliosis & Spine Research Group, McGill University, Montreal, QC, Canada H3A 2B4
3Department of Neurology & Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC, Canada H3A 3R8
4Faculty of Dentistry, McGill University, Montreal, QC, Canada H3G 0G1
5Department of Anesthesia, Faculty of Medicine, McGill University, Montreal, QC, Canada H3G 1Y6
6Department of Pharmacology & Therapeutics, Faculty of Medicine, McGill University, Montreal, QC, Canada H3G 1Y6

Received 2 December 2011; Revised 28 January 2012; Accepted 4 February 2012

Academic Editor: María Asunción Romero Molina

Copyright © 2012 Maral Tajerian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Grabois, “Management of chronic low back pain,” American Journal of Physical Medicine and Rehabilitation, vol. 84, no. 3, supplement, pp. S29–S41, 2005. View at Google Scholar
  2. X. Luo, R. Pietrobon, S. X. Sun, G. G. Liu, and L. Hey, “Estimates and patterns of direct health care expenditures among individuals with back pain in the United States,” Spine, vol. 29, no. 1, pp. 79–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. W. F. Stewart, J. A. Ricci, E. Chee, D. Morganstein, and R. Lipton, “Lost productive time and cost due to common pain conditions in the US workforce,” JAMA, vol. 290, no. 18, pp. 2443–2454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Devereaux, “Low back pain,” Medical Clinics of North America, vol. 93, no. 2, pp. 477–501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. V. Lindholm, T. Myllyla, and J. Sarvaranta, “The cold foot symptom in sciatica. A clinical and thermographic study,” Annales Chirurgiae et Gynaecologiae, vol. 70, no. 4, pp. 176–181, 1981. View at Google Scholar · View at Scopus
  6. O. P. Nygaard and S. I. Mellgren, “The function of sensory nerve fibers in lumbar radiculopathy: use of quantitative sensory testing in the exploration of different populations of nerve fibers and dermatomes,” Spine, vol. 23, no. 3, pp. 348–353, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. P. Raj, “Intervertebral disc: anatomy-physiology-pathophysiology-treatment,” Pain Practice, vol. 8, no. 1, pp. 18–44, 2008. View at Publisher · View at Google Scholar
  8. A. Mosek, D. Yarnitsky, A. D. Korczyn, and D. Niv, “The assessment of radiating low back pain by thermal sensory testing,” European Journal of Pain, vol. 5, no. 4, pp. 347–351, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Luoma, H. Riihimäki, R. Luukkonen, R. Raininko, E. Viikari-Juntura, and A. Lamminen, “Low back pain in relation to lumbar disc degeneration,” Spine, vol. 25, no. 4, pp. 487–492, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Takatalo, J. Karppinen, J. Niinimäki et al., “Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young finnish adults?” Spine, vol. 36, no. 25, pp. 2180–2189, 2011. View at Publisher · View at Google Scholar
  11. M. C. Jensen, M. N. Brant-Zawadzki, N. Obuchowski, M. T. Modic, D. Malkasian, and J. S. Ross, “Magnetic resonance imaging of the lumbar spine in people without back pain,” The New England Journal of Medicine, vol. 331, no. 2, pp. 69–73, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Boden, D. O. Davis, T. S. Dina, N. J. Patronas, and S. W. Wiesel, “Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation,” Journal of Bone and Joint Surgery—Series A, vol. 72, no. 3, pp. 403–408, 1990. View at Google Scholar · View at Scopus
  13. B. W. Koes, M. van Tulder, C. W. C. Lin, L. G. Macedo, J. McAuley, and C. Maher, “An updated overview of clinical guidelines for the management of non-specific low back pain in primary care,” European Spine Journal, vol. 19, no. 12, pp. 2075–2094, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. P. White, P. M. Arnold, D. C. Norvell, E. Ecker, and M. G. Fehlings, “Pharmacologic management of chronic low back pain: synthesis of the evidence,” Spine, vol. 36, no. 21, supplement, pp. S131–S143, 2011. View at Publisher · View at Google Scholar
  15. J. D. Bartleson, “Evidence for and against the use of opioid analgesics for chronic nonmalignant low back pain: a review,” Pain Medicine, vol. 3, no. 3, pp. 260–271, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Brown et al., “Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting,” Journal of Pain Research, vol. 4, pp. 373–384, 2011. View at Google Scholar
  17. M. H. Ossipov, Y. Lopez, D. Bian, M. L. Nichols, and F. Porreca, “Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury,” Anesthesiology, vol. 86, no. 1, pp. 196–204, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Przesmycki, J. A. Dzieciuch, S. J. Czuczwar, and Z. Kleinrok, “Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats,” European Journal of Pharmacology, vol. 337, no. 1, pp. 11–17, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Fairbanks and G. L. Wilcox, “Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine,” Journal of Pharmacology and Experimental Therapeutics, vol. 288, no. 3, pp. 1107–1116, 1999. View at Google Scholar · View at Scopus
  20. G. L. Wilcox, K. H. Carlsson, A. Jochim, and I. Jurna, “Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord,” Brain Research, vol. 405, no. 1, pp. 84–93, 1987. View at Google Scholar · View at Scopus
  21. M. H. Ossipov, S. Harris, P. Lloyd, and E. Messineo, “An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates,” Journal of Pharmacology and Experimental Therapeutics, vol. 255, no. 3, pp. 1107–1116, 1990. View at Google Scholar · View at Scopus
  22. M. H. Ossipov, S. Harris, P. Lloyd, E. Messineo, B. S. Lin, and J. Bagley, “Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy,” Anesthesiology, vol. 73, no. 6, pp. 1227–1235, 1990. View at Google Scholar · View at Scopus
  23. M. H. Ossipov, R. Lozito, E. Messineo, J. Green, S. Harris, and P. Lloyd, “Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis,” Life Sciences, vol. 47, no. 16, pp. L-71–L-76, 1990. View at Google Scholar · View at Scopus
  24. K. Drasner and H. L. Fields, “Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rate,” Pain, vol. 32, no. 3, pp. 309–312, 1988. View at Google Scholar · View at Scopus
  25. T. F. Meert and M. De Kock, “Potentiation of the analgesic properties of fentanyl-like opioids with α2-adrenoceptor agonists in rats,” Anesthesiology, vol. 81, no. 3, pp. 677–688, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Eisenach, R. D'Angelo, C. Taylor, and D. D. Hood, “An isobolographic study of epidural clonidine and fentanyl after cesarean section,” Anesthesia and Analgesia, vol. 79, no. 2, pp. 285–290, 1994. View at Google Scholar · View at Scopus
  27. M. J. Paech, T. J. G. Pavy, C. E. P. Orlikowski et al., “Postcesarean analgesia with spinal morphine, clonidine, or their combination,” Anesthesia and Analgesia, vol. 98, no. 5, pp. 1460–1466, 2004. View at Google Scholar · View at Scopus
  28. D. W. Coombs, R. L. Saunders, and J. D. Fratkin, “Continuous intrathrecal hydromorphine and clonidine for intractable cancer pain,” Journal of Neurosurgery, vol. 64, no. 6, pp. 890–894, 1986. View at Google Scholar
  29. H. E. Gruber, J. A. Ingram, K. Leslie, and E. N. Hanley, “Cellular, but not matrix, immunolocalization of SPARC in the human intervertebral disc: decreasing localization with aging and disc degeneration,” Spine, vol. 29, no. 20, pp. 2223–2228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. H. E. Gruber, E. H. Sage, H. J. Norton, S. Funk, J. Ingram, and E. N. Hanley, “Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse,” Journal of Histochemistry and Cytochemistry, vol. 53, no. 9, pp. 1131–1138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Millecamps, M. Tajerian, E. H. Sage, and L. S. Stone, “Behavioral signs of chronic back pain in the SPARC-null mouse,” Spine, vol. 36, no. 2, pp. 95–102, 2011. View at Publisher · View at Google Scholar
  32. M. Millecamps et al., “Lumbar intervertebral disc degeneration associated with axial and radiating low back pain in aging SPARC-null mice,” Pain. In press. View at Publisher · View at Google Scholar
  33. K. Norose, J. I. Clark, N. A. Syed et al., “SPARC deficiency leads to early-onset cataractogenesis,” Investigative Ophthalmology and Visual Science, vol. 39, no. 13, pp. 2674–2680, 1998. View at Google Scholar · View at Scopus
  34. R. A. Brekken, P. Puolakkainen, D. C. Graves, G. Workman, S. R. Lubkin, and E. H. Sage, “Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM,” The Journal of Clinical Investigation, vol. 111, no. 4, pp. 487–495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Steru, R. Chermat, B. Thierry, and P. Simon, “The tail suspension test: a new method for screening antidepressants in mice,” Psychopharmacology, vol. 85, no. 3, pp. 367–370, 1985. View at Google Scholar · View at Scopus
  37. Y. Choi, Y. W. Yoon, H. S. Na, S. H. Kim, and J. M. Chung, “Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain,” Pain, vol. 59, no. 3, pp. 369–376, 1994. View at Google Scholar · View at Scopus
  38. B. J. Jones and D. J. Roberts, “The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod,” Journal of Pharmacy and Pharmacology, vol. 20, no. 4, pp. 302–304, 1968. View at Google Scholar · View at Scopus
  39. M. Millecamps, M. V. Centeno, H. H. Berra et al., “d-Cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry,” Pain, vol. 132, no. 1-2, pp. 108–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. Tallarida and R. B. Murray, Manual of Pharmacological Calculations with Computer Programs, Springer, New York, NY, USA, 1987.
  41. R. J. Tallarida, “Statistical analysis of drug combinations for synergism,” Pain, vol. 49, no. 1, pp. 93–97, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Tajerian, S. Alvarado, M. Millecamps et al., “DNA methylation of SPARC and chronic low back pain,” Molecular Pain, vol. 7, article 65, 2011. View at Publisher · View at Google Scholar
  43. C. A. Fairbanks and G. L. Wilcox, “Moxonidine, a selective α2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 290, no. 1, pp. 403–412, 1999. View at Google Scholar · View at Scopus
  44. L. S. Stone, L. B. MacMillan, K. F. Kitto, L. E. Limbird, and G. L. Wilcox, “The α(2a) adrenergic receptor subtype mediates spinal analgesia evoked by α2 agonists and is necessary for spinal adrenergic-opioid synergy,” Journal of Neuroscience, vol. 17, no. 18, pp. 7157–7165, 1997. View at Google Scholar · View at Scopus
  45. A. C. Overland, K. F. Kitto, A. J. Chabot-Doré et al., “Protein kinase C mediates the synergistic interaction between agonists acting at α2-adrenergic and delta-opioid receptors in spinal cord,” Journal of Neuroscience, vol. 29, no. 42, pp. 13264–13273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Taylor-Stokes, S. Lobosco, J. Pike, A. B. Sadosky, and E. Ross, “Relationship between patient-reported chronic low back pain severity and medication resources,” Clinical Therapeutics, vol. 33, no. 11, pp. 1739–1748, 2011. View at Publisher · View at Google Scholar
  47. J. C. Eisenach, S. DuPen, M. Dubois, R. Miguel, and D. Allin, “Epidural clonidine analgesia for intractable cancer pain,” Pain, vol. 61, no. 3, pp. 391–399, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Morlion, “Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components,” Current Medical Research and Opinion, vol. 27, no. 1, pp. 11–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. C. A. Fairbanks, H. O. Nguyen, B. M. Grocholski, and G. L. Wilcox, “Moxonidine, a selective imidazoline-α2-adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice,” Anesthesiology, vol. 93, no. 3, pp. 765–773, 2000. View at Google Scholar · View at Scopus
  50. P. J. Siddall, M. Gray, S. Rutkowski, and M. J. Cousins, “Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report,” Pain, vol. 59, no. 1, pp. 147–148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  51. P. J. Siddall, A. R. Molloy, S. Walker, L. E. Mather, S. B. Rutkowski, and M. J. Cousins, “The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury,” Anesthesia and Analgesia, vol. 91, no. 6, pp. 1493–1498, 2000. View at Google Scholar · View at Scopus
  52. C. A. Fairbanks, L. S. Stone, and G. L. Wilcox, “Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis,” Pharmacology and Therapeutics, vol. 123, no. 2, pp. 224–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. X. H. Guo, C. A. Fairbanks, L. S. Stone, and H. H. Loh, “DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice,” Pain, vol. 104, no. 1-2, pp. 209–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. C. A. Fairbanks, L. S. Stone, K. F. Kitto, H. Oanh Nguyen, I. J. Posthumus, and G. L. Wilcox, “α2C-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 1, pp. 282–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. L. S. Stone, K. F. Kitto, J. C. Eisenach, C. A. Fairbanks, and G. L. Wilcox, “ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional α-2A- or α-2C-adrenergic receptors,” Journal of Pharmacology and Experimental Therapeutics, vol. 323, no. 3, pp. 899–906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. S. Riedl, S. A. Schnell, A. C. Overland et al., “Coexpression of α2A-adrenergic and δ-opioid receptors in substance P-containing terminals in rat dorsal horn,” Journal of Comparative Neurology, vol. 513, no. 4, pp. 385–398, 2009. View at Publisher · View at Google Scholar
  57. Z. Y. Wei, F. Karim, and S. C. Roerig, “Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels,” Journal of Pharmacology and Experimental Therapeutics, vol. 278, no. 3, pp. 1392–1407, 1996. View at Google Scholar · View at Scopus
  58. S. C. Roerig and K. M. Howse, “ω-agatoxin IVA blocks spinal morphine/clonidine antinociceptive synergism,” European Journal of Pharmacology, vol. 314, no. 3, pp. 293–300, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. Y. Wei and S. C. Roerig, “Spinal morphine/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase a activity,” Journal of Pharmacology and Experimental Therapeutics, vol. 287, no. 3, pp. 937–943, 1998. View at Google Scholar · View at Scopus
  60. C. Rios, I. Gomes, and L. A. Devi, “Interactions between δ opioid receptors and α2A-adrenoceptors,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 11, pp. 833–836, 2004. View at Publisher · View at Google Scholar
  61. B. A. Jordan, I. Gomes, C. Rios, J. Filipovska, and L. A. Devi, “Functional interactions between μ opioid and α2A-adrenergic receptors,” Molecular Pharmacology, vol. 64, no. 6, pp. 1317–1324, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Milligan, “G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function,” British Journal of Pharmacology, vol. 158, no. 1, pp. 5–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Illes and W. Norenberg, “Blockade of α2-adrenoceptors increases opioid μ-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 342, no. 5, pp. 490–496, 1990. View at Google Scholar
  64. B. Milne, F. W. Cervenko, K. Jhamandas, and M. Sutak, “Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat,” Anesthesiology, vol. 62, no. 1, pp. 34–38, 1985. View at Google Scholar · View at Scopus